ClinConnect ClinConnect Logo
Search / Trial NCT06842680

Testing Ultraprocessed Food Labels in Chile

Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 18, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how warning labels on ultraprocessed foods affect the choices that parents make when shopping for their children. Ultraprocessed foods are items that have been heavily processed and often contain unhealthy ingredients. The study will see if these warning labels make parents less likely to buy these foods, especially when they are also seeing other labels that warn about high levels of certain nutrients, like sodium and saturated fats. Participants will view three similar ultraprocessed products and share their thoughts on whether they would buy them and if they recognize them as ultraprocessed.

To be eligible for this study, you need to be at least 18 years old and a parent or guardian of a child aged 2 to 14 who has not been diagnosed with diabetes or related health issues. The trial is not yet recruiting participants, but once it begins, those who join will help researchers understand how effective these warning labels can be in helping families make healthier food choices.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years or older
  • Parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
  • Residing in Chile
  • Exclusion Criteria:
  • Less than 18 years old
  • Not parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
  • Not residing in Chile

About University Of North Carolina, Chapel Hill

The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.

Locations

Chapel Hill, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Aline D'Angelo Campos, MPP

Principal Investigator

University of North Carolina, Chapel Hill

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported